机构：[1]1 State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry, Peking Union Medical College, Beijing 100005, China[2]Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China [3]Department of Computer Science, Informatics Institute, and Christopher S. Bond Life Science Center, University of Missouri, Columbia MO 65211, USA [4]Department of Health Management and Informatics and Office of Medical Research, School of Medicine, University' of Missouri, Columbia MO 65212, USA [5]State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610000, China四川大学华西医院
Pulmonary fibrosis, a progressive chronic disease with a high mortality rate, has limited treatment options. Currently, lung transplantation remains the only effective treatment. Here we report that a small RNA, HJT-sRNA-m7, from a Chinese herbal medicine Hong Jing Tian (HJT, RHODIOHAE CRENULATAE RADIX ET RHIZOMA, Rhodiola crenulata) can effectively reduce the expressions of fibrotic hallmark genes and proteins both in alveolar in vitro and in mouse lung tissues in vivo. We also discovered over one hundred oil-soluble chemicals from HJT decoctions, most of which are found in lipid extracts from other Chinese herbals decoctions, including Pu Gong Ying (PGY, TARAXACI HERBA, Taraxacum mongolicum), Chuan Xin Lian (CXL, changed to "ANDROGRAPHIS HERBA, Andrographis paniculata"), and Jin Yin Hua (JYH, lonicera japonica or Honeysuckle). We identified the active component in these decoctions as two forms of phosphocholines, PC (18:0/18:2) and PC (16:0/18:2). These PCs potentially could form liposomes with small RNAs to enter human alveolar and gastric cells. Our experimental results suggest an unprecendent lipid complex route through which botanic small RNA can enter human bodies. Our results provide an innovative treatment strategy for oral delivery of siRNAs as therapeutic medication.
基金：
the Ministry of Science and Technology of China (2015CB553406), the National Natural Science Foundation of China (81230002, 81490531), and the Ministry' of Education (IRT1121, B08007).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|1 区生物学
小类|1 区生物学
最新[2023]版：
大类|2 区生物学
小类|2 区生物学
第一作者：
第一作者机构：[1]1 State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry, Peking Union Medical College, Beijing 100005, China
共同第一作者：
通讯作者：
通讯机构：[1]1 State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry, Peking Union Medical College, Beijing 100005, China[5]State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610000, China
推荐引用方式(GB/T 7714)：
Du Jianchao,Liang Zhu,Xu Jiantao,et al.Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7.[J].Science China Life Sciences.2019,62(3):309-320.doi:10.1007/s11427-017-9026-7.
APA：
Du Jianchao,Liang Zhu,Xu Jiantao,Zhao Yan,Li Xiaoyun...&Jiang Chengyu.(2019).Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7..Science China Life Sciences,62,(3)
MLA：
Du Jianchao,et al."Plant-derived phosphocholine facilitates cellular uptake of anti-pulmonary fibrotic HJT-sRNA-m7.".Science China Life Sciences 62..3(2019):309-320
生物学